Condition: Acute Lymphoblastic Leukemia (ALL) · Sponsor: Charite University, Berlin, Germany
The main goal of this study is to improve the outcome of children and adolescents with acute lymphoblastic leukemia with high risk first relapse by optimization of treatment strategies within a large international trial and the integration of new agents.
This description comes directly from the study's public registry record.
Arend von Stackelberg, MD · +49(0)30-450666 · arend.stackelberg@charite.de
Always discuss trial participation with your own doctor first.
| Australian & New Zealand Childhood Hematology & Oncology Group | Clayton, Victoria, Australia | Recruiting |
| St. Anna Kinderkrebsforschung, CCRI | Vienna, Austria | Recruiting |
| Hòpital Universitaire des Enfants Reine Fabiola | Brussels, Belgium | Recruiting |
| University Hospital Motol | Prague, Czechia | Recruiting |
| Copenhagen University Hospital (Rigshospitalet) | Copenhagen, Denmark | Not Yet Recruiting |
| Turku University Central Hospital | Turku, Finland | Recruiting |
| CHU Nice | Nice, France | Recruiting |
| Tel Aviv Sourasky Medical Centre | Tel Aviv, Israel | Recruiting |
| Ospedale Pediatrico Bambino Gesù | Roma, Italy | Recruiting |
| Prinses Máxima Centrum, Lundlaan | Utrecht, Netherlands | Recruiting |
| Oslo University Hospital | Oslo, Norway | Not Yet Recruiting |
| Dpt. SCT and Hematology/Oncology University Wroclaw | Wroclaw, Poland | Recruiting |
+ 3 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03590171